A prospective study of total and ionized serum calcium and fatal prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 2, 2009, Pages 575-578

  Skinner, Halcyon G ^a,c   Schwartz, Gary G ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ARTICLE; CALCIUM BLOOD LEVEL; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

AGED; CALCIUM; HUMANS; MALE; NUTRITION SURVEYS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 60549085754     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0915     Document Type: Article

References (25)

1. American Cancer Society. Cancer facts and figures 2008. Atlanta: American Cancer Society; 2008.
2. Schwartz GG. Vitamin D and the epidemiology of prostate cancer. Semin Dial 2005;18:276-89.
3. Ahn J, Peters U, Albanes D, et al. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 2008;100:796-804.
4. Tseng M, Breslow RA, Graubard BI, Ziegler RG. Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr 2005;81:1147-54.
5. Skinner HG, Schwartz GG. Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 2008;17:2302-5.
6. National Center for Health Statistics (U.S.). Plan and operation of the third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, MD. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; 1994.
7. Dickerson RN, Alexander KH, Minard G, Croce MA, Brown RO. Accuracy of methods to estimate ionized and "corrected" serum calcium concentrations in critically ill multiple trauma patients receivingspecialized nutrition support. JPEN J Parenter Enteral Nutr 2004;28:133-41.
8. Korn EL, Graubard BI. Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 1991;81:1166-73.
9. Cole DE, Peltekova VD, Rubin LA, et al. A986S polymorphism of the calcium-sensingreceptor and circulating calcium concentrations. Lancet 1999;353:112-5.
10. Valero-Politi J, Ginard-Salvá M, González-Alba JM. Annual rhythmic and non-rhythmic biological variation of magnesium and ionized calcium concentrations. Clin Chem Lab Med 2001;39:45-9.
11. Moe SM. Disorders involvingcalcium, phosphorus, and magnesium. Prim Care 2008;35:215-37.
12. Murray RM, GrillV, Crinis N, Ho PW, Davison J, Pitt P. Hypocalcemic and normocalcemic hyperparathyroidism in patients with advanced prostatic cancer. J Clin Endocrinol Metab 2001;86:4133-8.
13. Schwartz GG. Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases. Cancer Epidemiol Biomarkers Prev 2008;17:478-83.
14. Lin KI, Chattopadhyay N, Bai M, et al. Elevated extracellular calcium can prevent apoptosis via the calcium-sensingreceptor. Biochem Biophys Res Commun 1998;249:325-31.
15. Ritchie CK, Thomas KG, Andrews LR, Tindall DJ, Fitzpatrick LA. Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis. Prostate 1997;30:183-7.
16. 2+-sensingreceptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 2001;281:E1267-74.
17. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteo-clasts. Exp Cell Res 1988;175:266-76.
18. Liao J, Li X, Koh AJ, et al. Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions. Int J Cancer 2008;123:2267-78.
19. Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 2005;97:1768-77.
20. Giovannucci E, Rimm EB, Wolk A, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998;58:442-7.
21. Baron JA, Beach M, Wallace K, et al. Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 2005;14:586-9.
22. Jorde R, Sundsfjord J, Bonaa KH. Determinants of serum calcium in men and women. The Tromso Study. Eur J Epidemiol 2001;17:1117-23.
23. Ladenson JH, Bowers GN, Jr. Free calcium in serum. II. Rigor of homeostatic control, correlations with total serum calcium, and review of data on patients with disturbed calcium metabolism. Clin Chem 1973;19:575-82.
24. Muldowney WP, Mazbar SA. Rolaids-yogurt syndrome: a 1990s version of milk-alkali syndrome. Am J Kidney Dis 1996;27:270-2.
25. Neal DE, Donovan JL. Prostate cancer: to screen or not to screen? Lancet Oncol 2000;1:17-24.